Submitted by Anonymous (not verified) on 7 May 2025 - 11:22
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Bavencio, avelumab, Date of authorisation: 18/09/2017, Revision: 21, Status: Authorised